MAPT and Alzheimer disease: Intriguingly, the combination of female sex and APOEε4 genotype presents with more endophenotypes of AD, as female APOEε4 carriers experience greater AD risk, AD neuropathology, including phosphorylated tau, and cognitive impairment compared to male APOEε4 carriers [11–15].